Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2015 Mar 4;114(4):308–311.e4. doi: 10.1016/j.anai.2015.01.018

Table 4.

Prevalence ratio of short-acting β-agonist dispensing before and after the 2007 wildfires

BMI Group Prevalence ratio (95% CI)a
Underweight 0.98 (0.85–1.12)
Normal weight 1.00 (Reference)
Overweight 0.97 (0.92–1.02)
Obese 1.01 (0.97–1.06)
a

P value for the trend of .61.